Development of Digital Services for Parkinson's Disease

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
Healthy ControlsParkinson's Disease
Interventions
DEVICE

gait with cueing wearable device and neuro-ocular performance

"Participants will be invited to participate in the following sequential phases. Participants can participate in Phases as selected. Control participants will not be invited to Phase 4.~Phase 1. Lab testing \[2 hours\] Validation study of digital technology measures MachineMD and gaitQ to criterion metric of UPDRS.~Phase 2. home/community testing \[2 weeks daily\] Determine feasibility of daily measuring in the home of gaitQ to determine usability, acceptability, and day to day variability of measurement metrics and to determine concurrent validation of home metric to lab metrics to determine, reliability, concurrent validity of change, minimal detectable change and criterion validation to lab-based measures.~Phase 3. Lab retesting \[2 hours\] see Phase 1~Phase 4. Home/community intervention \[2 weeks\] Determine the potential for effect of the gaitQ vibration intervention from a 2-week exposure in the home."

Trial Locations (1)

EX1 2LU

RECRUITING

University of Exeter, Exeter

All Listed Sponsors
collaborator

University of Zurich

OTHER

collaborator

University Hospital, Zürich

OTHER

collaborator

machineMD AG

INDUSTRY

collaborator

GaitQ company

UNKNOWN

lead

University of Exeter

OTHER